Document is current
Any future updates will be listed below
-
Authors
Zhao, Ruiming
Lopez, Benjamin
Majumder, Nairrita
Kasparian, Aren
Hua, Punyanuch
Dai, Hui
Nayak, Maha
Zyrianova, Tatiana
Taylor, Clove
Ding, Yiwen
Sallee, Colin J.
Sapru, Anil
Goldstein, Steve A.N.
Schwingshackl, Andreas
-
Funding
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL159711)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL159711)
National Heart, Lung, and Blood Institute (HL159711)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL159711)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL146821)
National Heart, Lung, and Blood Institute (HL159711)
National Heart, Lung, and Blood Institute (HL146821)
National Center for Complementary and Integrative Health (AT012544)
National Center for Complementary and Integrative Health (AT012544)
National Center for Complementary and Integrative Health (AT012544)
National Center for Complementary and Integrative Health (AT012544)
National Center for Complementary and Integrative Health (AT012544)
American Heart Association (23CDA1052265)
American Heart Association (20TPA35490010)
U.S. Department of Defense (W81XWH2210040)
American Lung Association (IA-678511)
- License Information
-
More Information
Article History
Received: 24 July 2025
Accepted: 27 October 2025
First Online: 28 November 2025
Declarations
:
: Procedures involving animals were approved by the UCLA ARC/IACUC protocol # ARC-2015-047.
: Patents US 2019-0330285-A1 (HV1 MODULATORS AND USES) and US-2024-0254166-A1 (COMPOSITIONS AND METHODS FOR INHIBITING AN INFLAMMATORY RESPONSE AND TREATING INFLAMMATORY DISEASES) have been published.
